Shows enhanced anticancer efficacy in lung and gastric cells, indicating promising plant-derived therapeutic strategies.
The global rise in cancer occurrence, together with the spread of multidrug resistance, highlights the critical demand for innovative treatment strategies. Nano-delivery approaches have emerged as promising solutions that enhance bioavailability and facilitate targeted drug delivery. This study evaluated the anticancer efficacy of Nepeta glomerulosa extract and its silver-loaded nanoemulsion (Ag-N.g.Ext. NEs) against human lung (A549) and gastric (AGS) cells.MethodsNepeta glomerulosa was collected from the Binaloud Mountains, and a hydroalcoholic extract was obtained by maceration. Ag-N.g.Ext. NEs were prepared via high-energy emulsification and characterized by FTIR, SEM, DLS, ZP, and XRD. Cytotoxicity and apoptosis were assessed using MTT assay, DAPI staining, and Real-time PCR of TP53 and BAX genes.ResultsAg-N.g.Ext. NEs were spherical (confirmed by SEM) with a PSA (DLS) size of 269.5 nm, a negative zeta potential of -23.1 mV, and a non-crystalline structure. The IC₅₀ of the extract for A549 and AGS was 500 and 250 µg/mL, while the Ag-N.g.Ext. NEs showed enhanced potency with an IC₅₀ of 125 µg/mL. Apoptosis and gene expression were significantly higher in Ag-N.g.Ext. NEs-treated cells (p ≤ 0.05). TP53 expression increased 3.317-fold in A549 and 8.027-fold in AGS; BAX increased 3.877-fold in A549 and 2.351-fold in AGS.ConclusionsNanoemulsion-based delivery significantly enhances the anticancer efficacy of the extract by promoting apoptosis, offering a promising strategy for plant-derived therapeutics.
No takes yet. Share an insight, caveat, or question.
Sahebi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: